VANGUARD GROUP INC - ENTRADA THERAPEUTICS INC ownership

ENTRADA THERAPEUTICS INC's ticker is and the CUSIP is 29384C108. A total of 49 filers reported holding ENTRADA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.7%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of ENTRADA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$16,121,009
+5.5%
1,020,317
+1.0%
0.00%
Q2 2023$15,287,599
+13.5%
1,009,749
+8.7%
0.00%
Q1 2023$13,465,642
+8.2%
928,665
+0.9%
0.00%
Q4 2022$12,441,821
-9.3%
920,253
+5.8%
0.00%
Q3 2022$13,714,000
+47.7%
870,147
+14.1%
0.00%
Q2 2022$9,285,000
+129.8%
762,364
+77.1%
0.00%
Q1 2022$4,041,000
-44.4%
430,404
+1.3%
0.00%
Q4 2021$7,274,000424,9520.00%
Other shareholders
ENTRADA THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 4,425,784$75,769,00016.37%
5AM Venture Management, LLC 4,408,379$75,471,00014.16%
72 Investment Holdings, LLC 509,024$8,714,0007.73%
TCG Crossover Management, LLC 663,694$11,362,0005.32%
Redmile Group, LLC 1,954,420$33,460,0000.76%
StepStone Group LP 761,277$13,033,0000.74%
Baker Brothers Advisors 4,704,419$80,540,0000.39%
Avidity Partners Management LP 255,000$4,366,0000.09%
MOORE CAPITAL MANAGEMENT, LP 105,000$1,798,0000.04%
SUVRETTA CAPITAL MANAGEMENT, LLC 106,000$1,815,0000.04%
View complete list of ENTRADA THERAPEUTICS INC shareholders